Sermorelin – Research Peptide
Sermorelin research peptide is supplied as a high-purity synthetic growth hormone–releasing hormone (GHRH) analog intended strictly for laboratory investigation of peptide-mediated signaling pathways and endocrine receptor systems. In controlled research environments, Sermorelin is evaluated for its interaction with growth hormone–releasing hormone receptors and associated intracellular regulatory signaling mechanisms.
The 10mg configuration provides a standardized laboratory format suitable for experimental modeling, receptor pathway analysis, and endocrine signaling research.
Research Applications
Sermorelin is studied in laboratory environments for:
• Growth hormone–releasing hormone receptor pathway analysis
• Peptide-mediated endocrine signaling investigation
• Hormonal regulatory pathway modeling
• Pituitary signaling mechanism studies
• Experimental peptide signaling research
Its receptor-targeted signaling characteristics differentiate it from metabolic, regenerative, and mitochondrial research peptides studied in other experimental frameworks.
Product Specifications
• Compound: Sermorelin
• Strength: 10mg per vial
• Form: Lyophilized powder
• Purity: Research-grade (see COA)
• Storage: Refrigerated conditions recommended
• Intended Use: Laboratory Research Use Only
Certificate of Analysis (COA)
Each batch of Sermorelin 10mg research peptide is verified for purity and identity.
Current Active Batch: #ERL-2501-B074-T
View the full Certificate of Analysis here:
View Certificates of Analysis:
View 10mg COA
Research Use Notice
This compound is supplied strictly for laboratory research use only. Not for human or animal consumption.